{
    "id": 18485,
    "fullName": "TTK S611R",
    "impact": "missense",
    "proteinEffect": "no effect - predicted",
    "geneVariantDescriptions": [
        {
            "description": "TTK (MPS1) S611R lies within the kinase domain of the Ttk (Mps1) protein (UniProt.org). S611R confers resistance to Mps1 inhibitors by preventing binding to the Ttk (Mps1) protein, but otherwise has activity similar to wild-type (PMID: 26364596).",
            "references": [
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 4449,
                    "pubMedId": 26364596,
                    "title": "Molecular basis underlying resistance to Mps1/TTK inhibitors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26364596"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 7272,
        "geneSymbol": "TTK",
        "terms": [
            "TTK",
            "CT96",
            "ESK",
            "MPH1",
            "MPS1",
            "MPS1L1",
            "PYT"
        ]
    },
    "variant": "S611R",
    "createDate": "02/23/2016",
    "updateDate": "05/24/2018",
    "referenceTranscriptCoordinates": {
        "id": 122233,
        "transcript": "NM_003318",
        "gDna": "chr6:g.80035326T>G",
        "cDna": "c.1833T>G",
        "protein": "p.S611R",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 4709,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, cancer cell lines expressing Ttk (Mps1) S611R were resistant to inhibition by reversine (PMID: 26364596).",
            "molecularProfile": {
                "id": 18827,
                "profileName": "TTK S611R"
            },
            "therapy": {
                "id": 2327,
                "therapyName": "Reversine",
                "synonyms": null
            },
            "indication": {
                "id": 162,
                "name": "cancer",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 4449,
                    "pubMedId": 26364596,
                    "title": "Molecular basis underlying resistance to Mps1/TTK inhibitors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26364596"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 4707,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, cancer cell lines expressing Ttk (Mps1) S611R were resistant to inhibition by MPS1-IN-3 (PMID: 26364596).",
            "molecularProfile": {
                "id": 18827,
                "profileName": "TTK S611R"
            },
            "therapy": {
                "id": 3455,
                "therapyName": "MPS1-IN-3",
                "synonyms": null
            },
            "indication": {
                "id": 162,
                "name": "cancer",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 4449,
                    "pubMedId": 26364596,
                    "title": "Molecular basis underlying resistance to Mps1/TTK inhibitors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26364596"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 4694,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, cancer cell lines expressing Ttk (Mps1) S611R were resistant to inhibition by Cpd-5 (PMID: 26364596).",
            "molecularProfile": {
                "id": 18827,
                "profileName": "TTK S611R"
            },
            "therapy": {
                "id": 3465,
                "therapyName": "Cpd-5",
                "synonyms": null
            },
            "indication": {
                "id": 162,
                "name": "cancer",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 4449,
                    "pubMedId": 26364596,
                    "title": "Molecular basis underlying resistance to Mps1/TTK inhibitors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26364596"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 4714,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, cancer cell lines expressing Ttk (Mps1) S611R were resistant to inhibition by MPI-0479605 (PMID: 26364596).",
            "molecularProfile": {
                "id": 18827,
                "profileName": "TTK S611R"
            },
            "therapy": {
                "id": 3458,
                "therapyName": "MPI-0479605",
                "synonyms": null
            },
            "indication": {
                "id": 162,
                "name": "cancer",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 4449,
                    "pubMedId": 26364596,
                    "title": "Molecular basis underlying resistance to Mps1/TTK inhibitors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26364596"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 4703,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, cancer cell lines expressing Ttk (Mps1) S611R were resistant to inhibition by AZ3146 (PMID: 26364596).",
            "molecularProfile": {
                "id": 18827,
                "profileName": "TTK S611R"
            },
            "therapy": {
                "id": 3117,
                "therapyName": "AZ3146",
                "synonyms": null
            },
            "indication": {
                "id": 162,
                "name": "cancer",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 4449,
                    "pubMedId": 26364596,
                    "title": "Molecular basis underlying resistance to Mps1/TTK inhibitors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26364596"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 4699,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, cancer cell lines expressing Ttk (Mps1) S611R were resistant to inhibition by NMS-P715 (PMID: 26364596).",
            "molecularProfile": {
                "id": 18827,
                "profileName": "TTK S611R"
            },
            "therapy": {
                "id": 3107,
                "therapyName": "NMS-P715",
                "synonyms": null
            },
            "indication": {
                "id": 162,
                "name": "cancer",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 4449,
                    "pubMedId": 26364596,
                    "title": "Molecular basis underlying resistance to Mps1/TTK inhibitors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26364596"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 18827,
            "profileName": "TTK S611R",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 122234,
            "transcript": "XM_011536099",
            "gDna": "chr6:g.80035326T>G",
            "cDna": "c.1833T>G",
            "protein": "p.S611R",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 122233,
            "transcript": "NM_003318",
            "gDna": "chr6:g.80035326T>G",
            "cDna": "c.1833T>G",
            "protein": "p.S611R",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}